Abbott Laboratories (ABT)
Healthcare – PHARMACEUTICAL PREPARATIONS
- CEO
- Robert B. Ford
- Headquarters
- United States
- Employees
- 115,000
- Market Cap
- $186.9B
About Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
SentiSense also tracks daily options readings for Abbott Laboratories: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Abbott Laboratories stock analysis, sentiment tracking, and market intelligence on SentiSense.